Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CONDLIN MICHELLE

UEI: FBZ4JKVWBEA6CAGE: 4YQP7

CONDLIN MICHELLE is a federal contractor, registered under UEI FBZ4JKVWBEA6 and CAGE code 4YQP7. It has been awarded $95,951 across 4 federal contracts. Primary work spans Research and Development in Biotechnology. Top awarding agencies include Department Of Defense.

Contact Information

Registration and classification details

Address123 Main St, City, ST 12345

Registration

UEI Code

FBZ4JKVWBEA6

CAGE Code

4YQP7

Entity Structure

Sole Proprietorship

Established

N/A

Business Classifications

2U

NAICS Codes

813990Other Similar Organizations (except Business, Professional, Labor, and Political Organizations)(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Condlin Michelle operates as a small, independently owned entity based in Medway, Massachusetts, with a primary NAICS classification of 813990, which encompasses other similar organizations, typically indicating support services for nonprofit, civic, or advocacy groups. Given the absence of award hi...

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Defense$96.0K100%

Awards by NAICS

541711 - Research and Development in Biotechnology$96.0K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CONDLIN MICHELLE's top NAICS codes and agencies

PEO-M Unmanned Surface Vehicle (USV) Poseidon's Fury Collaboration Event (CE)

Solicitation # PEO_M_USV_Poseidon_s_Fury_CE

SOFWERX and the USSOCOM Program Executive Office Maritime (PEO-M) are hosting the Poseidon’s Fury Collaboration Event to accelerate the development of the Unmanned Surface Vehicle Mission-Aligned Reference Architecture (MARA), a standards-based framework designed to improve interoperability across Joint Force manned and unmanned maritime systems while eliminating redundant, service-specific platform development. This initiative is open exclusively to U.S. persons and involves a two-phase process beginning with a virtual collaboration event on August 26, 2026, where SOF operators and industry partners will engage in breakout sessions to define operational needs around user interface, autonomy, command and control, and platform effectiveness. Participation in this event is optional but strongly encouraged to align solutions with warfighter requirements, with registration closing August 14, 2026. Those who do not attend the CE may still submit capabilities for consideration during the Assessment Event, which opens on September 14, 2026, and closes October 2, 2026. A virtual Q&A session is available on September 23 for clarification on technical expectations. Selected submissions will undergo a downselect process, with winners invited to participate in a comprehensive on-water Assessment Event at Stennis Space Center, Mississippi, between November 2 and 20, 2026. Participants must demonstrate their USV capabilities in real-world conditions, with evaluations conducted by Subject Matter Experts from USSOCOM, JHU APL, WARCOM, and MARSOC using predefined technical and operational criteria. Successful performers may be transitioned to Phase 5, where potential pathways for follow-on acquisition include Other Transaction Authorities (OTAs) under 10 U.S.C. §4022, research agreements under 15 U.S.C. §3715, cooperative R&D agreements, experimental procurement under §4023, or prize competitions—potentially leading to non-competitive production awards based on successful prototype outcomes. All awardees must comply with NIST SP 800-171 for securing Controlled Unclassified Information, and eligibility is limited to U.S. persons and organizations capable of supporting USSOCOM’s unique maritime missions.

Department Of Defense

POSTED

DEADLINE

In Vitro ADMET AssaysThe contract titled In Vitro ADMET Assays calls for the performance of high-throughput in vitro screening focused on metabolic stability, hepatotoxicity, CYP450 enzyme interactions, and cellular permeability to support early-stage drug development. These assays are critical for evaluating the absorption, distribution, metabolism, excretion, and toxicity profiles of potential therapeutic candidates, enabling informed decisions before advancing compounds into costly clinical stages. The work will be conducted to meet the specific needs of the National Institutes of Health NIDA under the Department of Health and Human Services, with performance expected to occur in Bethesda. This is a subcontract opportunity under NAICS code 541711, which classifies it as research and development in the physical, engineering, and life sciences. The solicitation was posted on August 3, 2026, with a response deadline of August 18, 2026, at 7:00 PM Eastern Time. There is no set-aside classification specified, and no point of contact or detailed office address is provided in the data. Interested parties must submit their proposals before the deadline to be considered for award, with the expectation that the selected contractor will deliver reliable, scalable, and scientifically rigorous ADMET data to guide NIDA’s research initiatives in drug development.

National Institutes Of Health Nida

POSTED

DEADLINE

Genotoxicity and Carcinogenicity TestingThe contract seeks to perform in vitro and in vivo assays to assess the mutagenic and carcinogenic risks of drug candidates, ensuring compliance with regulatory safety standards for pharmaceutical development. The work is critical for identifying potential genetic toxicity and cancer-causing properties early in the drug evaluation process to support regulatory submissions and public health safeguards. The solicitation is issued as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with performance expected to take place in Bethesda. It falls under the NAICS code 541711 for research and development in the physical, engineering, and life sciences. The proposal must be submitted by August 18, 2026, with the opportunity posted on August 3, 2026. No set-aside provisions are specified, and the contract is open to qualified subcontractors with the technical capacity to deliver high-quality genotoxicity and carcinogenicity testing services.

National Institutes Of Health Nida

POSTED

DEADLINE

Safety Pharmacology (CNS, Cardiovascular, Pulmonary)The contract requires comprehensive safety pharmacology studies to evaluate adverse effects on the central nervous system, cardiovascular system, and pulmonary function, ensuring alignment with ICH safety guidelines. The work will involve detailed pharmacodynamic assessments to identify and characterize potential risks to major organ systems during early drug development, with a focus on identifying safety signals that could impact clinical translation. This subcontract, issued by the National Institutes of Health’s NIDA under the Department of Health and Human Services, is set to be performed in Bethesda and has a response deadline of August 18, 2026. The effort is classified under NAICS code 541711, indicating it pertains to research and development in the life sciences, and is aimed at supporting regulatory-compliant preclinical safety evaluations essential for pharmaceutical advancement.

National Institutes Of Health Nida

POSTED

DEADLINE

Toxicity Testing (Acute, Subacute, Subchronic, Chronic)The contract requires the performance of comprehensive toxicity testing in both rodent and non-rodent models to assess organ toxicity and establish safety margins for submission to regulatory authorities as part of an Investigational New Drug application. The scope includes acute, subacute, subchronic, and chronic studies designed to evaluate the potential adverse effects of pharmaceutical compounds across a range of exposure durations and dosages. The work must meet rigorous scientific standards to support regulatory filings and ensure the safety profile of investigational drugs is adequately characterized prior to human trials. This subcontract is issued under the National Institutes of Health, National Institute on Drug Abuse, within the Department of Health and Human Services, with the performance location specified as Bethesda. The North American Industry Classification System code 541711 identifies the work as research and development in the life sciences. The solicitation was posted on August 3, 2026, with a mandatory response deadline of August 18, 2026, at 7:00 PM. No set-aside provisions are specified, and the contract opportunity is open to eligible contractors capable of executing preclinical toxicology studies to support IND submissions.

National Institutes Of Health Nida

POSTED

DEADLINE

In Vivo Pharmacokinetic StudiesThe contract seeks to perform in vivo pharmacokinetic studies to assess the absorption, distribution, metabolism, and excretion of a drug candidate in both rodent and non-rodent species across multiple administration routes, with the goal of generating data to support an Investigational New Drug application. These studies will evaluate drug exposure over time to establish pharmacokinetic profiles critical for regulatory submission, requiring rigorous experimental design, appropriate species selection, and adherence to good laboratory practices. All work must be completed to ensure high-quality, reproducible results that meet FDA expectations for preclinical development. The solicitation is classified as a subcontract under NAICS code 541711, issued by the National Institutes of Health through the National Institute on Drug Abuse, part of the Department of Health and Human Services. Performance is expected to take place in Bethesda, and interested parties must submit their responses no later than August 18, 2026, at 7:00 PM. The opportunity was posted on August 3, 2026, and is open for competitive bidding with no specific set-aside designation. The contract does not provide a point of contact, and all inquiries must be directed through the official SAM.gov portal linked in the posting.

National Institutes Of Health Nida

POSTED

DEADLINE

Influenza Vaccine Clinical Trial ManagementThe contract pertains to the design and management of Phase I–III clinical trials for influenza vaccines, encompassing all critical aspects from protocol development and site selection to patient recruitment and regulatory reporting to the FDA. The work requires specialized expertise in infectious disease trials, with a focus on ensuring compliance with regulatory standards and timely submission of clinical data. The performance location is in Washington, DC, with a zip code of 20024, indicating the primary operational base for trial oversight and coordination. This is a subcontract under the Department of Health and Human Services, specifically managed by Barda – ASPR / DAAPPO / Barda DCMA, with a NAICS code of 541711 indicating scientific research and development services. The opportunity was posted on July 30, 2026, with a response deadline of August 15, 2026, at 9:00 PM ET. While no set-aside type or point of contact is specified, the emphasis on end-to-end clinical trial management suggests the subcontractor must possess a proven track record in vaccine development, regulatory engagement, and multi-site trial execution under federal health security initiatives.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.

Aspr Administration For Strategic Preparedness And Response

POSTED

DEADLINE

MARSOC: Automated Armory Collaboration Event (CE)

Solicitation # MARSOC_Automated_Armory_CE

MARSOC, in partnership with SOFWERX, is inviting U.S. industry, academia, and national laboratories to collaboratively develop a revolutionary automated armory system that eliminates manual inventory processes through a fully passive, image-based tracking solution. The initiative targets the modernization of serialized weapon and equipment accountability by replacing paper logs, handwritten forms, and RFID or radio-frequency systems with secure optical recognition and computer vision technologies. Participants are challenged to design a system that authenticates users via CAC, automatically logs equipment issuance and recovery through photographic scans, tracks item locations, and maintains tamper-proof audit trails—all without emitting any RF signals to preserve operational security. The effort is driven by the need to reduce human error, minimize administrative burden, and ensure absolute accountability in high-stakes special operations environments. The collaboration unfolds in stages: first, a mandatory submission deadline of 16 August 2026 for attendance at the in-person Collaboration Event on 17 September 2026 at SOFWERX in Florida, where stakeholders will engage directly with warfighters to refine requirements. Those unable to attend may still submit solutions by 20 October 2026 for the Assessment Event, which includes a virtual Q&A on 3 November and a downselect by 1 December. Finalists will present live demonstrations during the Assessment Event from 15 to 17 December 2026, with top-performing solutions potentially entering into non-traditional agreements under 10 U.S.C. Sections 4021, 4022, or other alternative contracting authorities such as OTAs, CRADAs, or prize competitions. Selected participants must comply with NIST SP 800-171 for handling Controlled Unclassified Information. Only U.S. persons and U.S. industry entities are eligible to participate, and success in this event may lead directly to follow-on production agreements without additional competition.

Department Of Defense

POSTED

DEADLINE

Induced Pluripotent Stem Cell (iPSC) Reprogramming ServicesThe contract entails the reprogramming of human articular chondrocytes and bone marrow cells into induced pluripotent stem cells using Sendai virus technology, with full support for culture expansion and cryopreservation of the resulting iPSCs. This subcontract is part of a research initiative led by the Department of Veterans Affairs through Rpo East, focused on advancing regenerative medicine techniques through advanced cellular reprogramming methods. The work requires precise adherence to protocols ensuring high efficiency, safety, and scalability of iPSC generation while maintaining cell viability and pluripotency throughout the process. The solicitation is open for responses until August 6, 2026, and falls under NAICS code 541711, indicating it is for research and development in the biological sciences. The agreement is structured as a subcontract, suggesting it will be awarded to a specialized contractor with expertise in stem cell biology and virology-based reprogramming. Performance is expected to meet rigorous quality standards for cellular products intended for potential therapeutic or diagnostic applications, with an emphasis on reproducibility and documentation. All deliverables must include verified iPSC lines archived through cryopreservation, ready for downstream use in future studies or clinical translation.

Rpo East (36C24E)

POSTED

DEADLINE

in about 16 hours

Contactless Iris Collection Collaboration Event

Solicitation # Contactless_Iris_Collection_Collaboration_Event

The U.S. Special Operations Command Program Executive Office for Tactical Information Systems, in partnership with SOFWERX, is conducting a structured initiative to evaluate the feasibility of using commercially available Android-based mobile devices for contactless iris image capture—without supplemental hardware—to meet biometric collection standards for integration into the Automated Biometric Identification System. This effort targets the validation of native mobile camera performance under public optical specifications against ISO and DoD biometric standards, aiming to reduce size, weight, and power requirements by leveraging built-in device lighting, including near-infrared wavelengths between 805 nm and 1,000 nm. To support this goal, a Collaboration Event is scheduled for 30 September 2026 at SOFWERX in Florida, limited to U.S. citizens and requiring registration by 28 August 2026. The event will facilitate direct engagement between warfighters and technology providers, enabling feedback loops on operational requirements and problem-solving, and is designed to prepare participants for the upcoming Assessment Event. Following the Collaboration Event, a submission window for the Assessment Event will open from 27 October to 27 November 2026, during which participants may submit their technologies for technical evaluation. A virtual Q&A session is scheduled for 11 November to clarify requirements. Submissions will be assessed on technical merit, with selected candidates invited to the Assessment Event on 19–21 January 2026, where they will present and demonstrate their solutions to an evaluation panel. Successful technologies may lead to negotiated awards under non-FAR authorities such as Other Transaction Authorities (10 U.S.C. §§ 4021, 4022), Cooperative Research and Development Agreements, or Business-to-Business agreements via SOFWERX’s Partnership Intermediary Agreement, with the potential for follow-on production without recompetition if prototype goals are met. Awardees must comply with NIST SP 800-171 standards for protecting Controlled Unclassified Information, and solutions must demonstrate significant matching scores across diverse populations, device-specific performance metrics, and reliable performance with unmodified consumer hardware.

Department Of Defense

POSTED

DEADLINE

4th Psychological Operations Group (4 POG)

Solicitation # 4_POG_event

The U.S. Special Operations Command’s 4th Psychological Operations Group, in partnership with SOFWERX, is seeking innovative software solutions to develop a unified, AI-enabled platform that integrates existing tools used for information dissemination and influence operations. This initiative aims to replace fragmented systems with a single, streamlined dashboard tailored to the operational needs of psychological operations personnel, enhancing efficiency and effectiveness across the full spectrum of mission workflows. Participation is open exclusively to U.S. citizens from industry, academia, and national laboratories, with a mandatory deadline of 5 August 2026 to request attendance at the Collaboration Event scheduled for 23–24 September 2026 at Smith Lake Recreational Center in North Carolina. The event will include structured breakout sessions to define problem sets and an optional industry expo to showcase technologies, enabling direct engagement with warfighters and potential collaborators. Following the Collaboration Event, a formal Assessment Event (AE) will open for submissions on 19 October 2026, with a virtual Q&A session on 4 November 2026 to clarify requirements. Submissions will be evaluated on technical merit, with selected participants invited to present their solutions during the AE from 12–14 January 2027. Successful candidates may be offered follow-on agreements under non-FAR authorities including Other Transaction Agreements (OTAs) under 10 U.S.C. § 4022, research and development partnerships via SOFWERX’s Partnership Intermediary Agreement, or other authorized mechanisms such as Cooperative Research and Development Agreements or prize competitions. Award recipients will be required to comply with NIST SP 800-171 standards for safeguarding Controlled Unclassified Information. Responses must be submitted by 5 August 2026 to secure entry into the process, with further instructions and criteria to be published closer to the AE submission window.

Department Of Defense

POSTED

DEADLINE

in about 6 hours

Emerging Animal & Zoonotic Disease Diagnostics Research

Sci Technology Acq Division

POSTED

DEADLINE

Small Business Subcontracting ParticipationThis contract opportunity is a total small business set-aside under the Federal Acquisition Regulation, reserved exclusively for certified small businesses including 8(a), HUBZone, WOSB, and SDVOSB firms. It is structured as a blanket purchase agreement for the supply of nuclear-grade chemicals, with eligible entities able to participate as suppliers or subcontractors. The NAICS code 325199 indicates the nature of the procurement involves other chemical product and preparation manufacturing, and the entire effort is dedicated to small business participation without competition from larger businesses. The opportunity is issued by the Department of Defense with a posted date of July 7, 2026, and responses must be submitted by August 6, 2026, before 9:00 p.m. Eastern Time. While specific performance locations and point of contact details are not provided, the agreement is designed to support small business involvement in mission-critical nuclear-grade chemical supply under federal procurement guidelines.

Department Of Defense

POSTED

DEADLINE

in about 23 hours

RFID and Supply Chain Visibility ServicesThe contract involves the supply and integration of passive RFID tags into chemical packaging to enable end-to-end traceability within Navy logistics systems, ensuring full compliance with Navy tracking standards and integration with WAWF and EDA platforms. The solution must provide real-time visibility, accurate inventory control, and secure data exchange to support military supply chain operations, with all systems designed to meet rigorous defense-grade reliability and security benchmarks. This is a small business set-aside subcontract under NAICS code 518210, exclusively available to small businesses as defined by the SBA, with a response deadline of August 6, 2026. The effort is sponsored by the Department of Defense and will be performed in alignment with federal acquisition regulations, though specific performance locations and points of contact are not detailed in the posting. The goal is to modernize chemical inventory management through automated, tamper-resistant tagging and seamless data interoperability across defense logistics networks.

Department Of Defense

POSTED

DEADLINE

in about 23 hours

Quality Assurance and Inspection SupportThe contract seeks a small business to provide technical quality assurance services in support of nuclear-grade chemical production, with a focus on DCMA NSEO Pre-Award Surveys, Government Source Inspection, and the documentation and tracking of non-conformances through Corrective Action Requests and Product Quality Deficiency Reports. The work is critical to ensuring compliance with stringent nuclear quality standards and requires expertise in inspecting and validating production processes prior to award and during execution. All activities must align with federal quality requirements and be conducted in accordance with applicable defense and nuclear regulatory frameworks. This is a subcontract under a Total Small Business Set-Aside, reserved exclusively for small businesses as defined by SBA regulations, and falls under NAICS code 541330 for scientific and technical consulting services. The opportunity was posted on July 7, 2026, with proposals due by August 6, 2026, and is sponsored by the Department of Defense. Performance location and specific site details are not specified, but the work will inherently involve engagement with federal nuclear production facilities and quality control infrastructure. The contractor must possess proven experience in aerospace or nuclear-grade quality systems, be fully prepared to interface with government inspectors, and maintain rigorous documentation practices for all non-conformance events to support compliance and continuous improvement.

Department Of Defense

POSTED

DEADLINE

in about 23 hours

Specialized Packaging and Preservation ServicesThis contract requires the provision of specialized packaging, preservation, and labeling services for chemical shipments destined for Navy nuclear facilities, strictly adhering to MIL-STD-2073 standards and additional Navy-specific requirements outlined in NAVSUPWSSDA07. The services must ensure the integrity, safety, and compliance of all chemical materials during transport and storage, with rigorous attention to preservation techniques and labeling protocols mandated by military nuclear operational protocols. All work must be performed to meet the exacting standards necessary for handling sensitive and hazardous materials in secure naval environments. The contract is structured as a subcontract under a Total Small Business Set-Aside, designated under SBA guidelines, and falls under the NAICS code 332994 for other fabricated metal product manufacturing. It is issued by the Department of Defense and is open for response until August 6, 2026, with submissions required by 9:00 PM Eastern Time. Interested small businesses must be prepared to demonstrate capability in military-grade packaging, preservation, and labeling, as well as familiarity with the unique operational demands of Navy nuclear facilities. The place of performance and point of contact information are unspecified, but performance is expected to support logistical needs across Navy nuclear sites as required by the contracting authority.

Department Of Defense

POSTED

DEADLINE

in about 23 hours

Nuclear-Grade Water Treatment Chemical SupplyThe contract is for the manufacture and supply of high-purity water treatment chemicals, specifically Sodium Phosphate Tribasic, intended for use in the secondary systems of U.S. Navy nuclear reactors. The chemicals must meet stringent military specifications to ensure operational safety and reliability in sensitive nuclear environments. This is a subcontract under a Total Small Business Set-Aside, meaning only small businesses certified by the SBA are eligible to bid, and the North American Industry Classification System code 325199 applies to this chemical manufacturing opportunity. The solicitation was posted on July 7, 2026, with responses due by August 6, 2026, and is managed by the Department of Defense. Performance is expected to support naval nuclear operations, though specific delivery locations are not detailed. The contract falls under federal procurement guidelines and emphasizes compliance with quality, purity, and military standards critical to the integrity of nuclear reactor water systems.

Department Of Defense

POSTED

DEADLINE

in about 23 hours